1. Reduction in experimental infarct size by recombinant human superoxide dismutase: Insights into the pathophysiology of reperfusion injury;Ambrosio;J Clin Invest,1986
2. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarctions in pigs;Amsterdam;Am J Physiol,1995
3. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes;Auchampach;J Pharmacol Exp Ther,1991
4. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning;Auchampach;Circulation,1992
5. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage;Black;J Cardiovasc Pharmacol,1992